Novartis | Kostnadene For Salg



Cost Of Sales Endring Dato
AbbVie USD 4B 394M 2025-03
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.24B 484M 2025-03
Bausch Health Companies USD 701M 26M 2025-03
Biogen USD 583.5M 55.2M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Indivior 44M 21M 2025-03
J&J USD 7.3B 189M 2025-03
Merck USD 2.76B 944M 2025-03
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Pacira USD 39.89M 1.02M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Prestige Brands USD 129.27M 2.86M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Zoetis USD 707M 8M 2024-12



Novartis Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.